Zika Virus Vaccines Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Type (DNA- based vaccines, Inactivated Vaccines, Live-attenuated Vaccines, mRNA Vaccines, Genetically Engineered Vaccines); Application (Therapeutic Vaccines, Preventive Vaccines); End User (Hospitals, Clinics)
Report Code: TIPRE00004599 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Zika Virus Vaccines Market - By Type
1.3.2 Zika Virus Vaccines Market - By Application
1.3.3 Zika Virus Vaccines Market - By End User
1.3.4 Zika Virus Vaccines Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ZIKA VIRUS VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ZIKA VIRUS VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ZIKA VIRUS VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. ZIKA VIRUS VACCINES - GLOBAL MARKET OVERVIEW
6.2. ZIKA VIRUS VACCINES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ZIKA VIRUS VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. DNA- BASED VACCINES
7.3.1. Overview
7.3.2. DNA- based vaccines Market Forecast and Analysis
7.4. INACTIVATED VACCINES
7.4.1. Overview
7.4.2. Inactivated Vaccines Market Forecast and Analysis
7.5. LIVE-ATTENUATED VACCINES
7.5.1. Overview
7.5.2. Live-attenuated Vaccines Market Forecast and Analysis
7.6. MRNA VACCINES
7.6.1. Overview
7.6.2. mRNA Vaccines Market Forecast and Analysis
7.7. GENETICALLY ENGINEERED VACCINES
7.7.1. Overview
7.7.2. Genetically Engineered Vaccines Market Forecast and Analysis
8. ZIKA VIRUS VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. THERAPEUTIC VACCINES
8.3.1. Overview
8.3.2. Therapeutic Vaccines Market Forecast and Analysis
8.4. PREVENTIVE VACCINES
8.4.1. Overview
8.4.2. Preventive Vaccines Market Forecast and Analysis
9. ZIKA VIRUS VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
10. ZIKA VIRUS VACCINES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Zika Virus Vaccines Market Overview
10.1.2 North America Zika Virus Vaccines Market Forecasts and Analysis
10.1.3 North America Zika Virus Vaccines Market Forecasts and Analysis - By Type
10.1.4 North America Zika Virus Vaccines Market Forecasts and Analysis - By Application
10.1.5 North America Zika Virus Vaccines Market Forecasts and Analysis - By End User
10.1.6 North America Zika Virus Vaccines Market Forecasts and Analysis - By Countries
10.1.6.1 United States Zika Virus Vaccines Market
10.1.6.1.1 United States Zika Virus Vaccines Market by Type
10.1.6.1.2 United States Zika Virus Vaccines Market by Application
10.1.6.1.3 United States Zika Virus Vaccines Market by End User
10.1.6.2 Canada Zika Virus Vaccines Market
10.1.6.2.1 Canada Zika Virus Vaccines Market by Type
10.1.6.2.2 Canada Zika Virus Vaccines Market by Application
10.1.6.2.3 Canada Zika Virus Vaccines Market by End User
10.1.6.3 Mexico Zika Virus Vaccines Market
10.1.6.3.1 Mexico Zika Virus Vaccines Market by Type
10.1.6.3.2 Mexico Zika Virus Vaccines Market by Application
10.1.6.3.3 Mexico Zika Virus Vaccines Market by End User
10.1.6.4 US Zika Virus Vaccines Market
10.1.6.4.1 US Zika Virus Vaccines Market by Type
10.1.6.4.2 US Zika Virus Vaccines Market by Application
10.1.6.4.3 US Zika Virus Vaccines Market by End User
10.2. EUROPE
10.2.1 Europe Zika Virus Vaccines Market Overview
10.2.2 Europe Zika Virus Vaccines Market Forecasts and Analysis
10.2.3 Europe Zika Virus Vaccines Market Forecasts and Analysis - By Type
10.2.4 Europe Zika Virus Vaccines Market Forecasts and Analysis - By Application
10.2.5 Europe Zika Virus Vaccines Market Forecasts and Analysis - By End User
10.2.6 Europe Zika Virus Vaccines Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Zika Virus Vaccines Market
10.2.6.1.1 Germany Zika Virus Vaccines Market by Type
10.2.6.1.2 Germany Zika Virus Vaccines Market by Application
10.2.6.1.3 Germany Zika Virus Vaccines Market by End User
10.2.6.2 France Zika Virus Vaccines Market
10.2.6.2.1 France Zika Virus Vaccines Market by Type
10.2.6.2.2 France Zika Virus Vaccines Market by Application
10.2.6.2.3 France Zika Virus Vaccines Market by End User
10.2.6.3 Italy Zika Virus Vaccines Market
10.2.6.3.1 Italy Zika Virus Vaccines Market by Type
10.2.6.3.2 Italy Zika Virus Vaccines Market by Application
10.2.6.3.3 Italy Zika Virus Vaccines Market by End User
10.2.6.4 Spain Zika Virus Vaccines Market
10.2.6.4.1 Spain Zika Virus Vaccines Market by Type
10.2.6.4.2 Spain Zika Virus Vaccines Market by Application
10.2.6.4.3 Spain Zika Virus Vaccines Market by End User
10.2.6.5 United Kingdom Zika Virus Vaccines Market
10.2.6.5.1 United Kingdom Zika Virus Vaccines Market by Type
10.2.6.5.2 United Kingdom Zika Virus Vaccines Market by Application
10.2.6.5.3 United Kingdom Zika Virus Vaccines Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Zika Virus Vaccines Market Overview
10.3.2 Asia-Pacific Zika Virus Vaccines Market Forecasts and Analysis
10.3.3 Asia-Pacific Zika Virus Vaccines Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Zika Virus Vaccines Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Zika Virus Vaccines Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Zika Virus Vaccines Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Zika Virus Vaccines Market
10.3.6.1.1 Australia Zika Virus Vaccines Market by Type
10.3.6.1.2 Australia Zika Virus Vaccines Market by Application
10.3.6.1.3 Australia Zika Virus Vaccines Market by End User
10.3.6.2 China Zika Virus Vaccines Market
10.3.6.2.1 China Zika Virus Vaccines Market by Type
10.3.6.2.2 China Zika Virus Vaccines Market by Application
10.3.6.2.3 China Zika Virus Vaccines Market by End User
10.3.6.3 India Zika Virus Vaccines Market
10.3.6.3.1 India Zika Virus Vaccines Market by Type
10.3.6.3.2 India Zika Virus Vaccines Market by Application
10.3.6.3.3 India Zika Virus Vaccines Market by End User
10.3.6.4 Japan Zika Virus Vaccines Market
10.3.6.4.1 Japan Zika Virus Vaccines Market by Type
10.3.6.4.2 Japan Zika Virus Vaccines Market by Application
10.3.6.4.3 Japan Zika Virus Vaccines Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Zika Virus Vaccines Market Overview
10.4.2 Middle East and Africa Zika Virus Vaccines Market Forecasts and Analysis
10.4.3 Middle East and Africa Zika Virus Vaccines Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Zika Virus Vaccines Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Zika Virus Vaccines Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Zika Virus Vaccines Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Zika Virus Vaccines Market
10.4.6.1.1 South Africa Zika Virus Vaccines Market by Type
10.4.6.1.2 South Africa Zika Virus Vaccines Market by Application
10.4.6.1.3 South Africa Zika Virus Vaccines Market by End User
10.4.6.2 Saudi Arabia Zika Virus Vaccines Market
10.4.6.2.1 Saudi Arabia Zika Virus Vaccines Market by Type
10.4.6.2.2 Saudi Arabia Zika Virus Vaccines Market by Application
10.4.6.2.3 Saudi Arabia Zika Virus Vaccines Market by End User
10.4.6.3 U.A.E Zika Virus Vaccines Market
10.4.6.3.1 U.A.E Zika Virus Vaccines Market by Type
10.4.6.3.2 U.A.E Zika Virus Vaccines Market by Application
10.4.6.3.3 U.A.E Zika Virus Vaccines Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Zika Virus Vaccines Market Overview
10.5.2 South and Central America Zika Virus Vaccines Market Forecasts and Analysis
10.5.3 South and Central America Zika Virus Vaccines Market Forecasts and Analysis - By Type
10.5.4 South and Central America Zika Virus Vaccines Market Forecasts and Analysis - By Application
10.5.5 South and Central America Zika Virus Vaccines Market Forecasts and Analysis - By End User
10.5.6 South and Central America Zika Virus Vaccines Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Zika Virus Vaccines Market
10.5.6.1.1 Brazil Zika Virus Vaccines Market by Type
10.5.6.1.2 Brazil Zika Virus Vaccines Market by Application
10.5.6.1.3 Brazil Zika Virus Vaccines Market by End User
10.5.6.2 Argentina Zika Virus Vaccines Market
10.5.6.2.1 Argentina Zika Virus Vaccines Market by Type
10.5.6.2.2 Argentina Zika Virus Vaccines Market by Application
10.5.6.2.3 Argentina Zika Virus Vaccines Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ZIKA VIRUS VACCINES MARKET, KEY COMPANY PROFILES
12.1. BHARAT BIOTECH INTERNATIONAL LTD
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GENEONE LIFE SCIENCE INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. HAWAII BIOTECH INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. IMMUNOVACCINE INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. INOVIO PHARMACEUTICALS, INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NEWLINK GENETICS CO
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANOFI S.A
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TAKEDA PHARMACEUTICAL CO. LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CERUS CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Zika Virus Vaccines Market - By Type
1.3.2 Zika Virus Vaccines Market - By Application
1.3.3 Zika Virus Vaccines Market - By End User
1.3.4 Zika Virus Vaccines Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ZIKA VIRUS VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ZIKA VIRUS VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ZIKA VIRUS VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. ZIKA VIRUS VACCINES - GLOBAL MARKET OVERVIEW
6.2. ZIKA VIRUS VACCINES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ZIKA VIRUS VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. DNA- BASED VACCINES
7.3.1. Overview
7.3.2. DNA- based vaccines Market Forecast and Analysis
7.4. INACTIVATED VACCINES
7.4.1. Overview
7.4.2. Inactivated Vaccines Market Forecast and Analysis
7.5. LIVE-ATTENUATED VACCINES
7.5.1. Overview
7.5.2. Live-attenuated Vaccines Market Forecast and Analysis
7.6. MRNA VACCINES
7.6.1. Overview
7.6.2. mRNA Vaccines Market Forecast and Analysis
7.7. GENETICALLY ENGINEERED VACCINES
7.7.1. Overview
7.7.2. Genetically Engineered Vaccines Market Forecast and Analysis
8. ZIKA VIRUS VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. THERAPEUTIC VACCINES
8.3.1. Overview
8.3.2. Therapeutic Vaccines Market Forecast and Analysis
8.4. PREVENTIVE VACCINES
8.4.1. Overview
8.4.2. Preventive Vaccines Market Forecast and Analysis
9. ZIKA VIRUS VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
10. ZIKA VIRUS VACCINES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Zika Virus Vaccines Market Overview
10.1.2 North America Zika Virus Vaccines Market Forecasts and Analysis
10.1.3 North America Zika Virus Vaccines Market Forecasts and Analysis - By Type
10.1.4 North America Zika Virus Vaccines Market Forecasts and Analysis - By Application
10.1.5 North America Zika Virus Vaccines Market Forecasts and Analysis - By End User
10.1.6 North America Zika Virus Vaccines Market Forecasts and Analysis - By Countries
10.1.6.1 United States Zika Virus Vaccines Market
10.1.6.1.1 United States Zika Virus Vaccines Market by Type
10.1.6.1.2 United States Zika Virus Vaccines Market by Application
10.1.6.1.3 United States Zika Virus Vaccines Market by End User
10.1.6.2 Canada Zika Virus Vaccines Market
10.1.6.2.1 Canada Zika Virus Vaccines Market by Type
10.1.6.2.2 Canada Zika Virus Vaccines Market by Application
10.1.6.2.3 Canada Zika Virus Vaccines Market by End User
10.1.6.3 Mexico Zika Virus Vaccines Market
10.1.6.3.1 Mexico Zika Virus Vaccines Market by Type
10.1.6.3.2 Mexico Zika Virus Vaccines Market by Application
10.1.6.3.3 Mexico Zika Virus Vaccines Market by End User
10.1.6.4 US Zika Virus Vaccines Market
10.1.6.4.1 US Zika Virus Vaccines Market by Type
10.1.6.4.2 US Zika Virus Vaccines Market by Application
10.1.6.4.3 US Zika Virus Vaccines Market by End User
10.2. EUROPE
10.2.1 Europe Zika Virus Vaccines Market Overview
10.2.2 Europe Zika Virus Vaccines Market Forecasts and Analysis
10.2.3 Europe Zika Virus Vaccines Market Forecasts and Analysis - By Type
10.2.4 Europe Zika Virus Vaccines Market Forecasts and Analysis - By Application
10.2.5 Europe Zika Virus Vaccines Market Forecasts and Analysis - By End User
10.2.6 Europe Zika Virus Vaccines Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Zika Virus Vaccines Market
10.2.6.1.1 Germany Zika Virus Vaccines Market by Type
10.2.6.1.2 Germany Zika Virus Vaccines Market by Application
10.2.6.1.3 Germany Zika Virus Vaccines Market by End User
10.2.6.2 France Zika Virus Vaccines Market
10.2.6.2.1 France Zika Virus Vaccines Market by Type
10.2.6.2.2 France Zika Virus Vaccines Market by Application
10.2.6.2.3 France Zika Virus Vaccines Market by End User
10.2.6.3 Italy Zika Virus Vaccines Market
10.2.6.3.1 Italy Zika Virus Vaccines Market by Type
10.2.6.3.2 Italy Zika Virus Vaccines Market by Application
10.2.6.3.3 Italy Zika Virus Vaccines Market by End User
10.2.6.4 Spain Zika Virus Vaccines Market
10.2.6.4.1 Spain Zika Virus Vaccines Market by Type
10.2.6.4.2 Spain Zika Virus Vaccines Market by Application
10.2.6.4.3 Spain Zika Virus Vaccines Market by End User
10.2.6.5 United Kingdom Zika Virus Vaccines Market
10.2.6.5.1 United Kingdom Zika Virus Vaccines Market by Type
10.2.6.5.2 United Kingdom Zika Virus Vaccines Market by Application
10.2.6.5.3 United Kingdom Zika Virus Vaccines Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Zika Virus Vaccines Market Overview
10.3.2 Asia-Pacific Zika Virus Vaccines Market Forecasts and Analysis
10.3.3 Asia-Pacific Zika Virus Vaccines Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Zika Virus Vaccines Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Zika Virus Vaccines Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Zika Virus Vaccines Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Zika Virus Vaccines Market
10.3.6.1.1 Australia Zika Virus Vaccines Market by Type
10.3.6.1.2 Australia Zika Virus Vaccines Market by Application
10.3.6.1.3 Australia Zika Virus Vaccines Market by End User
10.3.6.2 China Zika Virus Vaccines Market
10.3.6.2.1 China Zika Virus Vaccines Market by Type
10.3.6.2.2 China Zika Virus Vaccines Market by Application
10.3.6.2.3 China Zika Virus Vaccines Market by End User
10.3.6.3 India Zika Virus Vaccines Market
10.3.6.3.1 India Zika Virus Vaccines Market by Type
10.3.6.3.2 India Zika Virus Vaccines Market by Application
10.3.6.3.3 India Zika Virus Vaccines Market by End User
10.3.6.4 Japan Zika Virus Vaccines Market
10.3.6.4.1 Japan Zika Virus Vaccines Market by Type
10.3.6.4.2 Japan Zika Virus Vaccines Market by Application
10.3.6.4.3 Japan Zika Virus Vaccines Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Zika Virus Vaccines Market Overview
10.4.2 Middle East and Africa Zika Virus Vaccines Market Forecasts and Analysis
10.4.3 Middle East and Africa Zika Virus Vaccines Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Zika Virus Vaccines Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Zika Virus Vaccines Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Zika Virus Vaccines Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Zika Virus Vaccines Market
10.4.6.1.1 South Africa Zika Virus Vaccines Market by Type
10.4.6.1.2 South Africa Zika Virus Vaccines Market by Application
10.4.6.1.3 South Africa Zika Virus Vaccines Market by End User
10.4.6.2 Saudi Arabia Zika Virus Vaccines Market
10.4.6.2.1 Saudi Arabia Zika Virus Vaccines Market by Type
10.4.6.2.2 Saudi Arabia Zika Virus Vaccines Market by Application
10.4.6.2.3 Saudi Arabia Zika Virus Vaccines Market by End User
10.4.6.3 U.A.E Zika Virus Vaccines Market
10.4.6.3.1 U.A.E Zika Virus Vaccines Market by Type
10.4.6.3.2 U.A.E Zika Virus Vaccines Market by Application
10.4.6.3.3 U.A.E Zika Virus Vaccines Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Zika Virus Vaccines Market Overview
10.5.2 South and Central America Zika Virus Vaccines Market Forecasts and Analysis
10.5.3 South and Central America Zika Virus Vaccines Market Forecasts and Analysis - By Type
10.5.4 South and Central America Zika Virus Vaccines Market Forecasts and Analysis - By Application
10.5.5 South and Central America Zika Virus Vaccines Market Forecasts and Analysis - By End User
10.5.6 South and Central America Zika Virus Vaccines Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Zika Virus Vaccines Market
10.5.6.1.1 Brazil Zika Virus Vaccines Market by Type
10.5.6.1.2 Brazil Zika Virus Vaccines Market by Application
10.5.6.1.3 Brazil Zika Virus Vaccines Market by End User
10.5.6.2 Argentina Zika Virus Vaccines Market
10.5.6.2.1 Argentina Zika Virus Vaccines Market by Type
10.5.6.2.2 Argentina Zika Virus Vaccines Market by Application
10.5.6.2.3 Argentina Zika Virus Vaccines Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ZIKA VIRUS VACCINES MARKET, KEY COMPANY PROFILES
12.1. BHARAT BIOTECH INTERNATIONAL LTD
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GENEONE LIFE SCIENCE INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. HAWAII BIOTECH INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. IMMUNOVACCINE INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. INOVIO PHARMACEUTICALS, INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NEWLINK GENETICS CO
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANOFI S.A
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TAKEDA PHARMACEUTICAL CO. LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CERUS CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
- Bharat Biotech International Ltd.
- GeneOne Life Science Inc.
- GlaxoSmithKline Plc.
- Hawaii Biotech Inc.
- Immunovaccine Inc.
- Inovio Pharmaceuticals, Inc.
- NewLink Genetics Co.
- Sanofi S. A.
- Takeda Pharmaceutical Co. Ltd.
- Cerus Corporation
- Bharat Biotech International Ltd.
- GeneOne Life Science Inc.
- GlaxoSmithKline Plc.
- Hawaii Biotech Inc.
- Immunovaccine Inc.
- Inovio Pharmaceuticals, Inc.
- NewLink Genetics Co.
- Sanofi S. A.
- Takeda Pharmaceutical Co. Ltd.
- Cerus Corporation
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount